Pricing
Sign up

Vertex Pharmaceuticals

Go to market map
Similar Companies
+3 more
Sign in for full access
Short description
Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.
Description
Vertex Pharmaceuticals is a biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Company's strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies. Vertex's product pipeline is focused on viral diseases, cystic fibrosis, inflammation, autoimmune diseases, cancer, and pain.
Last funding
Nopepepe
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Boston, Massachusetts, United States, North America
Founded on
January 1, 1989
Exited on
July 25, 1991
Went public on
July 25, 1991
Stock symbol
VRTX
Non-profit?
No
Acquired?
No
Employees count
1001-5000
Revenue range
$1230 - 4560
Sign in for full access
Investors
Noaccess, Noaccess, Nopepepe, Cannot Access, Cannot Access, Noaccessforu, Nopepepe, Blurry Noaccess, Noway Youcantaccess
Sign in for full access
Founders
Joshua Boger, Larry Bock
Funding rounds count
6
Portfolio organisations count
Noaccess, Absolutely Noaccess
Sign in for full access
Lead investments count
2
Exits count
Blurry Noaccess, Blurry Noaccess
Sign in for full access
IPO exits count
2